ZA200403069B - Alpha2delta ligands to treat tinnitus. - Google Patents
Alpha2delta ligands to treat tinnitus. Download PDFInfo
- Publication number
- ZA200403069B ZA200403069B ZA200403069A ZA200403069A ZA200403069B ZA 200403069 B ZA200403069 B ZA 200403069B ZA 200403069 A ZA200403069 A ZA 200403069A ZA 200403069 A ZA200403069 A ZA 200403069A ZA 200403069 B ZA200403069 B ZA 200403069B
- Authority
- ZA
- South Africa
- Prior art keywords
- aminomethyl
- methyl
- acid
- acetic acid
- integer
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/131—Amines acyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4245—Oxadiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/443—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US35363202P | 2002-01-31 | 2002-01-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200403069B true ZA200403069B (en) | 2005-04-22 |
Family
ID=27663234
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200403069A ZA200403069B (en) | 2002-01-31 | 2004-04-22 | Alpha2delta ligands to treat tinnitus. |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US7026505B2 (https=) |
| EP (1) | EP1469841A1 (https=) |
| JP (1) | JP2005521664A (https=) |
| KR (1) | KR20040081478A (https=) |
| CN (1) | CN1625393A (https=) |
| AU (1) | AU2003201716B2 (https=) |
| BR (1) | BR0307411A (https=) |
| CA (1) | CA2474000A1 (https=) |
| CL (1) | CL2008000613A1 (https=) |
| IL (1) | IL162028A0 (https=) |
| MX (1) | MXPA04004105A (https=) |
| NZ (1) | NZ532624A (https=) |
| PL (1) | PL371944A1 (https=) |
| TW (1) | TW200306177A (https=) |
| WO (1) | WO2003063845A1 (https=) |
| ZA (1) | ZA200403069B (https=) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL189872B1 (pl) | 1996-07-24 | 2005-10-31 | Warner Lambert Co | Zastosowanie izobutylogaby i jej pochodnych do wytwarzania leku do leczenia bólu |
| US8048917B2 (en) | 2005-04-06 | 2011-11-01 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
| BRPI0408110A (pt) | 2003-03-07 | 2006-03-01 | Warner Lambert Co | derivados de beta-aminoácido substituìdos com tetrazol e oxadiazolona |
| EP1622569B1 (en) | 2003-04-24 | 2015-12-02 | Incyte Corporation | Aza spiro alkane derivatives as inhibitors of metallproteases |
| EP1622613A4 (en) * | 2003-05-14 | 2008-04-02 | Cytokinetics Inc | COMPOUNDS, COMPOSITIONS AND METHODS |
| CN101506140B (zh) * | 2006-08-24 | 2014-06-18 | 百时美施贵宝公司 | 环状11β-羟类固醇脱氢酶Ⅰ型抑制剂 |
| US7727978B2 (en) | 2006-08-24 | 2010-06-01 | Bristol-Myers Squibb Company | Cyclic 11-beta hydroxysteroid dehydrogenase type I inhibitors |
| EA200970483A1 (ru) * | 2006-11-14 | 2009-12-30 | Ксенопорт, Инк. | Применение пролекарств габапентина и прегабалина для лечения шума в ушах |
| US20080161393A1 (en) * | 2006-12-08 | 2008-07-03 | Barrett Ronald W | Use of prodrugs of GABA analogs for treating disease |
| ITMI20071492A1 (it) | 2007-07-24 | 2009-01-25 | S I I T Srl Servizio Internazi | "composizioni per il trattamento e la prevenzione di condizioni di vertigine e acufeni comprendenti citicolina, estratto di ginkgo biloba e flavoni dimerici di ginkgo biloba" |
| US8119658B2 (en) | 2007-10-01 | 2012-02-21 | Bristol-Myers Squibb Company | Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors |
| CN101260063B (zh) * | 2008-03-21 | 2013-06-19 | 北京润德康医药技术有限公司 | γ-氨基丁酸衍生物及其制备方法 |
| SG157299A1 (en) | 2008-05-09 | 2009-12-29 | Agency Science Tech & Res | Diagnosis and treatment of kawasaki disease |
| CN111718379A (zh) * | 2019-03-19 | 2020-09-29 | 海南长安国际制药有限公司 | 具有l1和l2结构的铂类物质及其制备方法和应用 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2460891C2 (de) * | 1974-12-21 | 1982-09-23 | Gödecke AG, 1000 Berlin | 1-Aminomethyl-1-cycloalkanessigsäuren und deren Ester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel |
| US4087544A (en) * | 1974-12-21 | 1978-05-02 | Warner-Lambert Company | Treatment of cranial dysfunctions using novel cyclic amino acids |
| US6197819B1 (en) * | 1990-11-27 | 2001-03-06 | Northwestern University | Gamma amino butyric acid analogs and optical isomers |
| WO1998017627A1 (en) * | 1996-10-23 | 1998-04-30 | Warner-Lambert Company | Substituted gamma aminobutyric acids as pharmaceutical agents |
| US6518289B1 (en) * | 1997-12-16 | 2003-02-11 | Pfizer, Inc. | 1-substituted-1-aminomethyl-cycloalkane derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders |
| NZ503980A (en) * | 1997-12-16 | 2002-09-27 | Warner Lambert Co | 4(3)substituted-4(3)-aminomethyl-(thio)pyran or -piperidine derivatives (= gabapentin analogues), pharmaceuticals thereof, and their use in the treatment of neurological disorders |
| DK1045839T3 (da) * | 1997-12-16 | 2004-07-05 | Warner Lambert Co | Hidtil ukendte aminer som farmaceutiske midler |
| EP1082306A1 (en) * | 1998-05-26 | 2001-03-14 | Warner-Lambert Company | Conformationally constrained amino acid compounds having affinity for the alpha2delta subunit of a calcium channel |
| GB9821179D0 (en) * | 1998-09-30 | 1998-11-25 | Merck Sharp & Dohme | Therapeutic use |
| RS50352B (sr) * | 1999-06-10 | 2009-11-10 | Warner-Lambert Company Llc., | Monosupstituisane 3-propil gama-aminobuterne kiseline |
| HN2000000224A (es) * | 1999-10-20 | 2001-04-11 | Warner Lambert Co | Aminoacidos biciclicos como agentes farmaceuticos |
| US6620829B2 (en) * | 2000-10-17 | 2003-09-16 | Warner-Lambert Company | Method of treating noninflammatory cartilage damage |
-
2003
- 2003-01-20 CN CNA038031388A patent/CN1625393A/zh active Pending
- 2003-01-20 KR KR10-2004-7011809A patent/KR20040081478A/ko not_active Ceased
- 2003-01-20 MX MXPA04004105A patent/MXPA04004105A/es active IP Right Grant
- 2003-01-20 BR BR0307411-0A patent/BR0307411A/pt not_active IP Right Cessation
- 2003-01-20 AU AU2003201716A patent/AU2003201716B2/en not_active Ceased
- 2003-01-20 WO PCT/IB2003/000232 patent/WO2003063845A1/en not_active Ceased
- 2003-01-20 NZ NZ532624A patent/NZ532624A/en unknown
- 2003-01-20 EP EP03700417A patent/EP1469841A1/en not_active Ceased
- 2003-01-20 JP JP2003563539A patent/JP2005521664A/ja not_active Withdrawn
- 2003-01-20 PL PL03371944A patent/PL371944A1/xx not_active Application Discontinuation
- 2003-01-20 CA CA002474000A patent/CA2474000A1/en not_active Abandoned
- 2003-01-20 IL IL16202803A patent/IL162028A0/xx unknown
- 2003-01-29 US US10/353,367 patent/US7026505B2/en not_active Expired - Fee Related
- 2003-01-30 TW TW092102235A patent/TW200306177A/zh unknown
-
2004
- 2004-04-22 ZA ZA200403069A patent/ZA200403069B/en unknown
-
2005
- 2005-12-21 US US11/314,126 patent/US7138542B2/en not_active Expired - Fee Related
-
2008
- 2008-02-28 CL CL2008000613A patent/CL2008000613A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NZ532624A (en) | 2007-05-31 |
| US20060100281A1 (en) | 2006-05-11 |
| AU2003201716B2 (en) | 2008-04-17 |
| IL162028A0 (en) | 2005-11-20 |
| CL2008000613A1 (es) | 2008-11-07 |
| TW200306177A (en) | 2003-11-16 |
| WO2003063845A1 (en) | 2003-08-07 |
| US7138542B2 (en) | 2006-11-21 |
| US20030176504A1 (en) | 2003-09-18 |
| MXPA04004105A (es) | 2004-11-29 |
| KR20040081478A (ko) | 2004-09-21 |
| CN1625393A (zh) | 2005-06-08 |
| EP1469841A1 (en) | 2004-10-27 |
| JP2005521664A (ja) | 2005-07-21 |
| CA2474000A1 (en) | 2003-08-07 |
| PL371944A1 (en) | 2005-07-11 |
| US7026505B2 (en) | 2006-04-11 |
| BR0307411A (pt) | 2004-12-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA200403069B (en) | Alpha2delta ligands to treat tinnitus. | |
| JP2000515486A (ja) | アダマンタン誘導体の内耳炎治療向け使用 | |
| EP2054047B1 (en) | Methods for treating acute acoustic trauma | |
| US20070021352A1 (en) | Prevention and treatment of hearing disorders | |
| DK1714960T3 (en) | NEW THERAPEUTIC MEDICINE FOR AMYOTROPHIC LATERAL SCLEROSIS (ALS) OR DISEASE AScribed | |
| ZA200007174B (en) | Method for the treatment of insomnia. | |
| ZA200601551B (en) | Combination comprising an Alpha-2 Delta ligand and SSRI and/or SNRI for treatment of depression and anxiety disorders | |
| AU2002311784A1 (en) | Acute pharmacologic augmentation of psychotherapy with enhancers of learning or conditioning | |
| WO2002078629A2 (en) | Acute pharmacologic augmentation of psychotherapy with enhancers of learning or conditioning | |
| Camras et al. | Efficacy and adverse effects of medications used in the treatment of glaucoma | |
| EP3004353B1 (en) | Bumetanide for treating neurodegenerative diseases with parkinsonian syndromes | |
| JP2012148995A (ja) | 難聴疾患の予防又は治療剤 | |
| KR100823668B1 (ko) | 신경성 통증 치료 및 예방약 | |
| WO2009089366A2 (en) | Suppression of cancer growth and metastasis using nordihydroguaiaretic acid derivatives with metabolic modulators | |
| EP0542807B1 (en) | Use of 2-phenyl-1,2-benzisoselenazol-3(2h)-one | |
| RS64304B1 (sr) | Betahistin, ili njegova farmaceutski prihvatljiva so, i inhibitor monoaminske oksidaze, za upotrebu u lečenju ili prevenciji jednog ili više simptoma vrtoglavice kod subjekta | |
| US20100062987A1 (en) | Anticonvulsive pharmaceutical compositions | |
| ZA200409848B (en) | Method treating attention deficit hyperactivity disorder | |
| HUP0202339A2 (hu) | Kortizol antagonisták alkalmazása szívelégtelenség kezelésére | |
| US20060035976A1 (en) | Methods of preventing headaches with norepinephrine precursors | |
| CN101507720A (zh) | 调节血管生成和癌细胞增殖的方法 | |
| WO2022184841A1 (en) | Cxcl8 inhibitor and pharmaceutical composition thereof for use in the treatment of seizures | |
| WO2022037006A1 (zh) | 一种止痛止痒药物组合物及其应用方法 | |
| CN1761467B (zh) | 2-取代-吡啶-甲胺衍生物在制备用于治疗神经性和心理性慢性疼痛症状的药物的用途 | |
| US20080039500A1 (en) | Cerebral Infarction Suppressant |